These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 35618202)

  • 1. Characterization of phospholipid-modified lung surfactant in vitro and in a neonatal ARDS model reveals anti-inflammatory potential and surfactant lipidome signatures.
    Kupsch S; Eggers LF; Spengler D; Gisch N; Goldmann T; Fehrenbach H; Stichtenoth G; Krause MF; Schwudke D; Schromm AB
    Eur J Pharm Sci; 2022 Aug; 175():106216. PubMed ID: 35618202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic roles for surfactant-inositols and -phosphatidylglycerols in a neonatal piglet ARDS model: a translational study.
    Spengler D; Winoto-Morbach S; Kupsch S; Vock C; Blöchle K; Frank S; Rintz N; Diekötter M; Janga H; Weckmann M; Fuchs S; Schromm AB; Fehrenbach H; Schütze S; Krause MF
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L32-L53. PubMed ID: 28860142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18:1/18:1-Dioleoyl-phosphatidylglycerol prevents alveolar epithelial apoptosis and profibrotic stimulus in a neonatal piglet model of acute respiratory distress syndrome.
    Preuß S; Scheiermann J; Stadelmann S; Omam FD; Winoto-Morbach S; Lex D; von Bismarck P; Adam-Klages S; Knerlich-Lukoschus F; Wesch D; Held-Feindt J; Uhlig S; Schütze S; Krause MF
    Pulm Pharmacol Ther; 2014 Jun; 28(1):25-34. PubMed ID: 24140177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits.
    Zebialowicz Ahlström J; Massaro F; Mikolka P; Feinstein R; Perchiazzi G; Basabe-Burgos O; Curstedt T; Larsson A; Johansson J; Rising A
    Respir Res; 2019 Nov; 20(1):245. PubMed ID: 31694668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bovine surfactant in the treatment of pneumonia-induced-neonatal acute respiratory distress syndrome (NARDS) in neonates beyond 34 weeks of gestation: a multicentre, randomized, assessor-blinded, placebo-controlled trial.
    Rong Z; Mo L; Pan R; Zhu X; Cheng H; Li M; Yan L; Lang Y; Zhu X; Chen L; Xia S; Han J; Chang L
    Eur J Pediatr; 2021 Apr; 180(4):1107-1115. PubMed ID: 33084980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory and anti-viral actions of anionic pulmonary surfactant phospholipids.
    Numata M; Voelker DR
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jun; 1867(6):159139. PubMed ID: 35240310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-inflammatory and antiviral properties of anionic pulmonary surfactant phospholipids.
    Numata M; Kandasamy P; Voelker DR
    Immunol Rev; 2023 Aug; 317(1):166-186. PubMed ID: 37144896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.
    Kuronuma K; Mitsuzawa H; Takeda K; Nishitani C; Chan ED; Kuroki Y; Nakamura M; Voelker DR
    J Biol Chem; 2009 Sep; 284(38):25488-500. PubMed ID: 19584052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant Injury in the Early Phase of Severe Meconium Aspiration Syndrome.
    Autilio C; Echaide M; Shankar-Aguilera S; Bragado R; Amidani D; Salomone F; Pérez-Gil J; De Luca D
    Am J Respir Cell Mol Biol; 2020 Sep; 63(3):327-337. PubMed ID: 32348683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
    Notter RH; Shapiro DL; Ohning B; Whitsett JA
    Chem Phys Lipids; 1987 Jun; 44(1):1-17. PubMed ID: 3607971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Unsettled Promise: The Newborn Piglet Model of Neonatal Acute Respiratory Distress Syndrome (NARDS). Physiologic Data and Systematic Review.
    Spengler D; Rintz N; Krause MF
    Front Physiol; 2019; 10():1345. PubMed ID: 31736777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.
    Sun B; Curstedt T; Lindgren G; Franzén B; Alaiya AA; Calkovská A; Robertson B
    Eur Respir J; 1997 Sep; 10(9):1967-74. PubMed ID: 9311487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inositol-trisphosphate reduces alveolar apoptosis and pulmonary edema in neonatal lung injury.
    Preuss S; Stadelmann S; Omam FD; Scheiermann J; Winoto-Morbach S; von Bismarck P; Knerlich-Lukoschus F; Lex D; Adam-Klages S; Wesch D; Held-Feindt J; Uhlig S; Schütze S; Krause MF
    Am J Respir Cell Mol Biol; 2012 Aug; 47(2):158-69. PubMed ID: 22403805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the New Generation Synthetic Reconstituted Surfactant CHF5633 on Pro- and Anti-Inflammatory Cytokine Expression in Native and LPS-Stimulated Adult CD14+ Monocytes.
    Glaser K; Fehrholz M; Curstedt T; Kunzmann S; Speer CP
    PLoS One; 2016; 11(1):e0146898. PubMed ID: 26790130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps.
    De Luca D; Cogo P; Kneyber MC; Biban P; Semple MG; Perez-Gil J; Conti G; Tissieres P; Rimensberger PC
    Crit Care; 2021 Feb; 25(1):75. PubMed ID: 33618742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant reduces extravascular lung water and invasion of polymorphonuclear leukocytes into the lung in a piglet model of airway lavage.
    Krause MF; Wiemann T; Reisner A; Orlowska-Volk M; Köhler H; Ankermann T
    Pulm Pharmacol Ther; 2005; 18(2):129-39. PubMed ID: 15649855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization and in vivo comparison of the pulmonary outcomes of Poractant alfa and Calsurf in ventilated preterm rabbits.
    Guo X; Luo S; Amidani D; Rivetti C; Pieraccini G; Pioselli B; Catinella S; Murgia X; Salomone F; Xu Y; Dong Y; Sun B
    PLoS One; 2020; 15(3):e0230229. PubMed ID: 32168331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids.
    Notter RH; Gupta R; Schwan AL; Wang Z; Shkoor MG; Walther FJ
    PeerJ; 2016; 4():e2635. PubMed ID: 27812430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effect of surfactant on inflammatory cytokines during endotoxin-induced lung injury in rodents.
    Mittal N; Sanyal SN
    J Immunotoxicol; 2011; 8(4):274-83. PubMed ID: 21767135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.